NZ244239A - Genetically engineered tyrosine kinase receptors - Google Patents
Genetically engineered tyrosine kinase receptorsInfo
- Publication number
- NZ244239A NZ244239A NZ24423992A NZ24423992A NZ244239A NZ 244239 A NZ244239 A NZ 244239A NZ 24423992 A NZ24423992 A NZ 24423992A NZ 24423992 A NZ24423992 A NZ 24423992A NZ 244239 A NZ244239 A NZ 244239A
- Authority
- NZ
- New Zealand
- Prior art keywords
- receptor
- signalling
- pharmaceutical composition
- incompetent
- growth factor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19914129533 DE4129533A1 (de) | 1991-09-05 | 1991-09-05 | Mutierter wachstumsfaktorrezeptor als arzneimittel und seine verwendung zur behandlung von krebs |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ244239A true NZ244239A (en) | 1995-07-26 |
Family
ID=6439926
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ24423992A NZ244239A (en) | 1991-09-05 | 1992-09-07 | Genetically engineered tyrosine kinase receptors |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0667899A1 (sv) |
JP (1) | JPH07502884A (sv) |
CN (1) | CN1071586A (sv) |
AU (1) | AU669857B2 (sv) |
CA (1) | CA2117073A1 (sv) |
DE (1) | DE4129533A1 (sv) |
FI (1) | FI941053A (sv) |
MX (1) | MX9205084A (sv) |
NO (1) | NO940778L (sv) |
NZ (1) | NZ244239A (sv) |
PT (1) | PT100844A (sv) |
WO (1) | WO1993005148A1 (sv) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6465623B2 (en) | 1995-05-02 | 2002-10-15 | Garvan Institute Of Medical Research | GDU, a novel signalling protein |
AUPN274295A0 (en) * | 1995-05-02 | 1995-05-25 | Garvan Institute Of Medical Research | GDU, a novel signalling protein |
US6790614B1 (en) | 1999-11-19 | 2004-09-14 | Novartis Ag | Selectable cell surface marker genes |
ES2741546T3 (es) | 2004-03-31 | 2020-02-11 | Massachusetts Gen Hospital | Método para determinar la respuesta del cáncer a tratamientos dirigidos al receptor del factor de crecimiento epidérmico |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0325224B1 (en) * | 1988-01-22 | 1996-07-31 | ZymoGenetics, Inc. | Methods of producing secreted receptor analogs |
WO1990008160A1 (en) * | 1989-01-20 | 1990-07-26 | Imperial Cancer Research Technology Ltd. | Growth factor receptor-like peptides without tyrosine-kinase activity |
GB9001466D0 (en) * | 1990-01-23 | 1990-03-21 | Erba Carlo Spa | Extracellular form of the human fibroblast growth factor receptor |
ATE155813T1 (de) * | 1989-05-19 | 1997-08-15 | Genentech Inc | Her2 extrazellulare domäne |
EP0491007B1 (en) * | 1989-09-08 | 1996-03-13 | The Johns Hopkins University | Structural alterations of the egf receptor gene in human gliomas |
-
1991
- 1991-09-05 DE DE19914129533 patent/DE4129533A1/de not_active Ceased
-
1992
- 1992-09-04 MX MX9205084A patent/MX9205084A/es unknown
- 1992-09-04 PT PT10084492A patent/PT100844A/pt not_active Application Discontinuation
- 1992-09-05 CN CN 92111396 patent/CN1071586A/zh active Pending
- 1992-09-07 JP JP5504969A patent/JPH07502884A/ja active Pending
- 1992-09-07 NZ NZ24423992A patent/NZ244239A/en unknown
- 1992-09-07 WO PCT/EP1992/002058 patent/WO1993005148A1/de not_active Application Discontinuation
- 1992-09-07 EP EP92918949A patent/EP0667899A1/de not_active Withdrawn
- 1992-09-07 CA CA 2117073 patent/CA2117073A1/en not_active Abandoned
- 1992-09-07 AU AU25185/92A patent/AU669857B2/en not_active Ceased
-
1994
- 1994-03-04 FI FI941053A patent/FI941053A/sv not_active Application Discontinuation
- 1994-03-04 NO NO940778A patent/NO940778L/no unknown
Also Published As
Publication number | Publication date |
---|---|
MX9205084A (es) | 1993-05-01 |
CA2117073A1 (en) | 1993-03-18 |
NO940778L (no) | 1994-05-04 |
FI941053A0 (sv) | 1994-03-04 |
EP0667899A1 (de) | 1995-08-23 |
WO1993005148A1 (de) | 1993-03-18 |
CN1071586A (zh) | 1993-05-05 |
AU2518592A (en) | 1993-04-05 |
FI941053A (sv) | 1994-04-08 |
AU669857B2 (en) | 1996-06-27 |
NO940778D0 (no) | 1994-03-04 |
DE4129533A1 (de) | 1993-03-11 |
JPH07502884A (ja) | 1995-03-30 |
PT100844A (pt) | 1994-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5705157A (en) | Methods of treating cancerous cells with anti-receptor antibodies | |
JP5719270B2 (ja) | 腫瘍治療のための組成物および方法 | |
EP0865448B1 (en) | Apoptosis induced by monoclonal antibody anti-her2 | |
US7138508B2 (en) | Inhibitor protein of the wnt signal pathway | |
EA021867B1 (ru) | Иммуномодулирующие полипептиды, полученные из il-2, и их применение для лечения рака и хронических инфекций | |
EA004793B1 (ru) | Химерный белок растворимого рецептора интерлейкина-6/лиганда, его аналоги и способы применения | |
Ban et al. | Isolation and characterization of a 2.3-kilobase-pair cDNA fragment encoding the binding domain of the bovine leukemia virus cell receptor | |
CN109810995B (zh) | 编码car的核苷酸序列、表达该car的robo1 car-nk细胞及其制备和应用 | |
JP3492364B2 (ja) | 過剰増殖性細胞の複製阻害方法 | |
JP2001512319A (ja) | 細胞のNF−κB活性化を調節するための組成物および方法 | |
US20060025362A1 (en) | Guanylate binding protein (GBP-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation | |
NZ244239A (en) | Genetically engineered tyrosine kinase receptors | |
JPH09505557A (ja) | ヒト腫瘍細胞の遺伝子形質転換によるヒト腫瘍の治療 | |
UA75565C2 (uk) | Фармацевтична сполука для стимулювання ангіогенезу (варіанти), фармацевтична сполука для інгібування ангіогенезу (варіанти) та спосіб модулювання ангіогенезу з їх використанням | |
CN100497382C (zh) | 突变型Bik的抗肿瘤效果 | |
JP6820123B2 (ja) | Ccl3変異体を含む融合タンパク質およびその用途 | |
EP0967276A2 (en) | Anti-tumor agent comprising salmosin | |
CA2042605A1 (en) | Cytolysis inhibitor proteins (cli), dna sequences coding for said proteins, and plasmids, host organisms, and processes for obtaining said proteins | |
JP2003507337A (ja) | チロシンキナーゼrafおよびrasを用いて脈管形成を調節するために有用な方法および組成物 | |
DK170781B1 (da) | Human leukoregulin og biologisk aktive underenheder deraf, fremgangsmåde til fremstilling og til oprensning af human leukoregulin, biologisk aktivt materiale indeholdende human leukoregulin samt celle, som producerer human leukoregulin | |
CN1948342B (zh) | 一种新的候选癌基因hRabJ来源的HLA-A2限制性表位多肽及其应用 | |
JP2697725B2 (ja) | 悪性腫瘍治療用キット | |
BR102013025838A2 (pt) | Proteínas de fusão endo-bax e endo-bax-endo e suas sequências de aminoácidos |